Complaint Counsel's Post Trial Brief - Federal Trade Commission

442. There are no indications in Duke's IE that Feverew has been evaluated in clinical trals
for its effcacy in treating cancer. (R18 (Duke, Dep. at 157); Duke, Tr. 533-34).
James K. Dews
443. Dews is not familiar with the product GDU. In fact, he does not have a clue what GDU
is. (R19 (Dews, Dep. at 55)).
444. The active chemical in tuerc is curcumin, and curcumn is ''very good at reducing
inflamation." (R19 (Dews, Dep. at 65)).
445. One canot say that reducing inflamation is a cure for any paricular disease. (R 19
(Dews, Dep. at 66)).
Sallv B. LaMont. N.D.
446. LaMont does not know whether the product GDU elimates tuors. (R22 (LaMont,
Dep. at 92)).
447. LaMont does not know whether GDU is effective in curg cancer. (R22 (LaMont, Dep.
at 43); LaMont, Tr. 581-82).
448. LaMont does not know whether GDU is effective in the treatment of cancer. (R22
(LaMont, Dep. at 92); LaMont, Tr. 581).
449. LaMont is not aware of any clincal studies ofGDU. (R22 (LaMont, Dep. at 42-43)).
450. LaMont agrees that it would be fai to stay that it's impossible today to state the degree to
which GDU is effective in the treatment or cure of cancer. (R22 (LaMont, Dep. at 45­
46)).
451. LaMont does not know whether GDU on its own at its dose would elimate tuors.
(R22 (LaMont, Dep. at 74-75)).
452. LaMont recommends curcumn to inbit inflamation. (R22 (LaMont, Dep. at 27)).
453. LaMont recommends that her patients use tuerc in their diet and have them
supplement it in a dose of around 300 miligrams a day. (R22 (LaMont, Dep. at 27)).
454. LaMont's understanding is that 300 millgrams of tueric per day has been commonly
found to be effective at reducing inflamation. (R22 (LaMont, Dep. at 28)).
455. LaMont thnks that takg tueric in high doses can inhbit clot formation. (R22
(LaMont, Dep. at 30-31)).
456. One clinical study that LaMont can mention came out last month and involved the use of
tuerc or curcumn in patients with pancreatic cancer. (R22 (LaMont, Dep. at 38-39)).
457. According to LaMont, the 2008 study involving patients with pancreatic cancer used
eight grams of a curcumoid a day. (R22 (LaMont, Dep. at 38-39)).
38